Micro Labs is looking forward to double its growth of its nephrology product portfolio. The company which entered the nephrology space in 2007-08 already has six products for dialysis and transplant marketed through its Foresee division.
The nephrology portfolio covers tacrolimus, MMF, erythropoietin, calcium polystyrene sulphonate, lanthonum carbonate and iron sucrose injection. Ending this fiscal, the range is set to register a four fold growth with earnings of Rs 12 crore compared to last year's Rs 3.5 crore. Going by this year's performance, Micro Labs has set a target of Rs 24 crore for next fiscal. The increasing number of patients and efficacy of drugs are its key growth factors.
"We already have a solid cardiac-diabetes product portfolio. These chronic life style disorders also affect renal systems. The dialysis and transplant drugs have created an integrated basket of products," Pradeep K Bharadwaj, vice president, sales & marketing Foresee Division, Micro Labs Limited told Pharmabiz.
Last year, as part of the company's corporate social responsibility initiative on World Kidney Day, it approached doctors to identify poor patients. Micro Labs provided free 800 erythropoietin and 4000 iron sucrose injections. This year, Micro Labs went on a patient awareness drive through doctors across India to educate them on early signs of renal problems. The effort will not help to the population to access early medical attention but would also help companies to expand rural market opportunities, said Bharadwaj.
Bangalore-based Micro Labs Ltd. in fiscal 2008-09 registered earnings to the tune of Rs. 1,200 crore. The company exports to 60 countries including regulated markets. In the domestic market, company's therapeutic presence covers cardiology, diabetology, fever-pain management, anti-infectives, neuro-psychiatry, dermatology and ophthalmology. These products are manufactured out of its 11 production plants designed for oral solids, oral liquids, topicals. It has 13 divisions: Micro Labs, Micro Nova, Brown & Burk, Eros Pharma, Micro Vision, Carsyon, Cardicare, Synapse, Gratia, Micro Healthcare, Foresee and Diabetes Task Force (DTF) which market over 300 brands. The popular brands are Dolo-650, Amlong, Tripride, Hopace, Dolopar, Lutivit, Secalia, to name a few.